SCHEMBL29923692

SCHEMBL29923692

COc1ccc2ncnc(Cl)c2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.56
GRM1 Q13255 1/20 0.56
EGFR P00533 8/20 0.54
KDM4E B2RXH2 1/20 0.54
POLB P06746 1/20 0.54
CSF1R P07333 2/20 0.52
LCK P06239 2/20 0.50
ENPP1 P22413 2/20 0.50
MAP4K4 O95819 1/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
HPGD P15428 1/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
KMT2A Q03164 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
PDE4A P27815 1/20 0.48
PDE4B Q07343 1/20 0.48
PDE4C Q08493 1/20 0.48
PDE4D Q08499 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL591893 1.00 MAPT (0.56) MAPTGRM1EGFRKDM4EPOLB
Hydrochloric Acid SCHEMBL28102779 0.98 MAPT (0.55) MAPTGRM1EGFRKDM4EPOLB
SCHEMBL144584 0.86 EGFR (0.54) MAPTGRM1EGFRKDM4EPOLB
SCHEMBL29461134 0.86 EGFR (0.54) MAPTGRM1EGFRKDM4EPOLB
Hydrochloric Acid SCHEMBL28824441 0.84 EGFR (0.52) MAPTGRM1EGFRKDM4EPOLB
SCHEMBL28817807 0.83 ENPP1 (0.55) MAPTKDM4EENPP1MAP4K4ALDH1A1
SCHEMBL1012882 0.82 FBP1 (0.53) MAPTGRM1EGFRENPP1ALDH1A1
SCHEMBL12779098 0.80 MAPT (0.58) MAPTGRM1EGFRKDM4ECSF1R
SCHEMBL535605 0.79 ALDH1A1 (0.44) MAPTKDM4EPOLBALDH1A1LMNA
SCHEMBL7795285 0.79 ENPP1 (0.45) EGFRLCKENPP1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4622970-A1 INHIBITORS OF RIPK2 AND MEDICAL USES THEREOF ODYSSEY THERAPEUTICS, INC. (US) 2025-10-01 EP disclosed
WO-2025007113-A2 MITOCHONDRIAL COMPLEX I INHIBITORS WITH REDUCED PHOSPHODIESTERASE INHIBITION OHIO STATE INNOVATION FOUNDATION (US) 2025-01-02 WO disclosed
WO-2024112854-A1 INHIBITORS OF RIPK2 AND MEDICAL USES THEREOF ODYSSEY THERAPEUTICS, INC. (US) 2024-05-30 WO disclosed
EP-4055013-A1 WDR5 INHIBITORS AND MODULATORS Vanderbilt University (US) 2022-09-14 EP disclosed